AN2 Therapeutics raises $40M privately [Seeking Alpha]
AN2 Therapeutics, Inc. (ANTX)
US:NYSE Investor Relations:
ir.antheminc.com
Company Research
Source: Seeking Alpha
The financing involves selling ~8.25M shares at $2.85 per share, plus pre-funded warrants for up to 5.79M shares at $2.84999 each. The proceeds are expected to fund R&D and operations. The private placement is expected to close on March 10, 2026. The stock price traded 3% higher on Monday during pre-market trade. More on AN2 Therapeutics Seeking Alpha's Quant Rating on AN2 Therapeutics Historical earnings data for AN2 Therapeutics Financial information for AN2 Therapeutics
Show less
Read more
Impact Snapshot
Event Time:
ANTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANTX alerts
High impacting AN2 Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
ANTX
News
- AN2 Therapeutics Announces $40 Million Private Placement Financing [Yahoo! Finance]Yahoo! Finance
- AN2 Therapeutics Announces $40 Million Private Placement FinancingBusiness Wire
- AN2 Therapeutics Announces Plans to Advance Oral Epetraborole into Phase 2 Study for Polycythemia Vera (PV) [Yahoo! Finance]Yahoo! Finance
- AN2 Therapeutics Announces Plans to Advance Oral Epetraborole into Phase 2 Study for Polycythemia Vera (PV)Business Wire
- AN2 Therapeutics to Participate in Fireside Chat at Leerink Global Healthcare Conference [Yahoo! Finance]Yahoo! Finance
ANTX
Earnings
- 5/13/25 - Miss
ANTX
Sec Filings
- 3/16/26 - Form SCHEDULE
- 3/13/26 - Form SCHEDULE
- 3/13/26 - Form SCHEDULE
- ANTX's page on the SEC website